Clinical Trials for Igen Biotech

Explore 12 clinical trials worldwide

Showing 1-12 of 12 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Igen Biotech

Clinical Trials (12)

NCT07209020
HealiAid Collagen Wound Dressing in Patients Undergoing Breast Tumor Surgery
NARecruiting
60 participants
Started: May 20, 2025 · Completed: May 31, 2027
3 conditions1 sponsor3 locations
NCT06994546
ArtiBest for Knee Osteoarthritis
NARecruiting
60 participants
Started: Mar 11, 2025 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT06730009
Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients
PHASE1/PHASE2Recruiting
42 participants
Started: Oct 21, 2024 · Completed: Aug 31, 2029
2 conditions1 sponsor1 location
NCT06252935
Effectiveness and Safety of Collagen Membrane (FormaAid®) in the Treatment of Periodontal Regeneration
NARecruiting
60 participants
Started: Jul 30, 2024 · Completed: Oct 31, 2025
3 conditions2 sponsors1 location
NCT06458595
Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
PHASE1/PHASE2Recruiting
44 participants
Started: Jun 28, 2024 · Completed: Dec 28, 2026
1 condition1 sponsor1 location
NCT04347967
Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)
PHASE1Not yet recruiting
18 participants
Started: Jan 1, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05657301
Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration
PHASE1Recruiting
25 participants
Started: Oct 16, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor7 locations
NCT05672121
Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
PHASE1/PHASE2Recruiting
42 participants
Started: Feb 6, 2023 · Completed: Dec 28, 2026
1 condition1 sponsor1 location
NCT05394714
A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study
PHASE1Recruiting
18 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04097652
Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke
PHASE1Recruiting
9 participants
Started: Dec 5, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03631420
Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants
PHASE1Recruiting
9 participants
Started: Oct 26, 2018 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06825858
A Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH658 Gene Therapy in Participants with Neovascular Age-related Macular Degeneration
PHASE1Not yet recruiting
9 participants
1 condition1 sponsor0 locations